{
  "id": "38133e049df6f09f",
  "title": "STAT+: A sign biotech is back? Four drugmakers go public, raising nearly $1 billion in all",
  "description": "The biotech IPO, a nearly forgotten vestige of the startup playbook, has returned in full force.",
  "content": "The biotech IPO, a nearly forgotten vestige of the startup playbook, has returned in full force.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/02/06/biotech-ipos-public-offerings-eikon/?utm_campaign=rss",
  "published_at": "2026-02-06T17:20:54+00:00",
  "fetched_at": "2026-02-07T00:27:41.919994+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ipo",
    "ai",
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: A sign biotech is back? Four drugmakers go public, raising nearly $1 billion in all",
    "description": "The biotech IPO, a nearly forgotten vestige of the startup playbook, has returned in full force.",
    "url": "https://www.statnews.com/2026/02/06/biotech-ipos-public-offerings-eikon/?utm_campaign=rss",
    "published": "2026-02-06T17:20:54+00:00",
    "source": "STAT"
  }
}